Bausch Health Cos Total Change in Assets/Liabilities 2010-2024 | BHC
Bausch Health Cos total change in assets/liabilities from 2010 to 2024. Total change in assets/liabilities can be defined as the sum of all line items in the Asset/Liability section of the Cash Flows Statement
Bausch Health Cos Annual Total Change in Assets/Liabilities
(Millions of US $) |
| 2024 |
$7 |
| 2023 |
$-582 |
| 2022 |
$-396 |
| 2021 |
$-128 |
| 2020 |
$-366 |
| 2019 |
$-318 |
| 2018 |
$18 |
| 2017 |
$844 |
| 2016 |
$-110 |
| 2015 |
$-668 |
| 2014 |
$-557 |
| 2013 |
$-378 |
| 2012 |
$-253 |
| 2011 |
$-137 |
| 2010 |
$-22 |
| 2009 |
$-10 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.381B |
$9.625B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
